A novel cell-surface protein CSP82 on bone marrow stem cells and a cytosolic phosphoprotein DP58 (ankyrinRD 34B) are involved in promyeloid progenitor induction

被引:3
作者
Al-Shaibi, Nisreen [1 ]
Ghosh, Swapan K. [1 ]
机构
[1] Indiana State Univ, Dept Life Sci, Terre Haute, IN 47809 USA
关键词
Receptor lactoferrin CSP82; Bone marrow differentiation; Common myeloid progenitor (CMP); Dendritic cells; DP58; phosphoprotein; AnkyrinRD; 34B; PERIPHERAL LYMPHOID ORGANS; DENDRITIC CELLS; IDENTIFICATION; PRECURSORS; EXPRESSION; DIFFERENTIATION; LACTOFERRIN; ESTROGEN; VACCINES; LINEAGE;
D O I
10.1016/j.cellimm.2009.05.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The molecular events associated with the development of common myeloid progenitor (CMP) remain largely unknown. This study reports that a novel glycosylphosphatidylinositol (GPI)-anchored lactoferrin CSP82 on uninitiated mouse bone marrow cells (BMC) may be involved in inducing pro-DC from CMP. By peptide mass fingerprinting, CSP82 has been identified as the mouse lactoferrin precursor, but unlike the latter, it occurs as a GPI-linked cell-surface protein. The GPI-linkage was demonstrated on BMC-derived immunoprecipitates and by other techniques. Furthermore, BMC and hematopoietic stem EM cells following incubation with either CSP82 peptide antibody or purified Reagent A yielded CMP-like progenitors (BM4 cells). These progenitors expressed a previously reported cytosolic phosphoprotein DP58 (AnkRD 34B protein). Continued cultivation of BMC in media containing only anti-CSP82 antibody led to DC-like cells, that bore phenotypic and endocytic resemblance with those obtained using GM-CSF. The results suggest that a receptor lactoferrin on BMC may be an important non-cytokine mechanism for early promyeloid progenitor differentiation. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:172 / 180
页数:9
相关论文
共 41 条
[31]   Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes [J].
Munn, DH ;
Sharma, MD ;
Hou, D ;
Baban, B ;
Lee, JR ;
Antonia, SJ ;
Messina, JL ;
Chandler, P ;
Koni, PA ;
Mellor, AL .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :280-290
[32]   Developmental stages of myeloid dendritic cells in mouse bone marrow [J].
Nikolic, T ;
de Bruijn, MFTR ;
Lutz, MB ;
Leenen, PJM .
INTERNATIONAL IMMUNOLOGY, 2003, 15 (04) :515-524
[33]   Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin [J].
Olweus, J ;
BitMansour, A ;
Warnke, R ;
Thompson, PA ;
Carballido, J ;
Picker, LJ ;
LundJohansen, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12551-12556
[34]  
PENTECOST BT, 1987, J BIOL CHEM, V262, P10134
[35]   Dendritic cell fusion vaccines for cancer immunotherapy [J].
Rosenblatt, J ;
Kufe, D ;
Avigan, D .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (05) :703-715
[36]   Glycosyl phosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C [J].
Sharom, FJ ;
Lehto, MT .
BIOCHEMISTRY AND CELL BIOLOGY, 2002, 80 (05) :535-549
[37]  
STEINMAN RM, 1975, J EXP MED, V141, P804
[38]   IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE .2. FUNCTIONAL PROPERTIES IN-VITRO [J].
STEINMAN, RM ;
COHN, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 139 (02) :380-397
[40]  
Timmerman JM, 1999, ANNU REV MED, V50, P507